Back to Search Start Over

Supplemental Table 1. from Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs

Authors :
David S. Hong
Albiruni R.A. Razak
Lillian L. Siu
Funda Meric-Bernstam
Alona Zer
Denis L.F. Jardim
Kenneth Hess
Diogo D.G. Bugano
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Drugs Approved by the U.S. Food and Drug Administration by April 30, 2014, That Were Included in the Analysis

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....c8cd3716e29f6c23d1879c8242890515
Full Text :
https://doi.org/10.1158/1078-0432.22467939